Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
PPAR Research|August 14, 2010
The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic DiseaseTeresa Coll, Emma Barroso, David Alvarez-Guardia, et al.Endocrinology|February 27, 2010
Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cellsTeresa Coll, David Alvarez-Guardia, Emma Barroso, et al.Cell Communication and Signaling : CCS|September 11, 2020
SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2Emma Barroso, Rosalía Rodríguez-Rodríguez, Mohammad Zarei, et al.Cell Communication and Signaling : CCS|December 19, 2024
PPARβ/δ upregulates the insulin receptor β subunit in skeletal muscle by reducing lysosomal activity and EphB4 levelsJue-Rui Wang, Javier Jurado-Aguilar, Emma Barroso, et al.International Journal of Molecular Sciences|March 21, 2018
PPARβ/δ: A Key Therapeutic Target in Metabolic DisordersXavier Palomer, Emma Barroso, Javier Pizarro-Delgado, et al.International Journal of Cardiology|April 29, 2014
PPARβ/δ attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cellsXavier Palomer, Eva Capdevila-Busquets, Gaia Botteri, et al.British Journal of Pharmacology|March 31, 2019
Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21Mohammad Zarei, Eugènia Pujol, Tania Quesada-López, et al.Cell Reports|August 11, 2021
GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPKDavid Aguilar-Recarte, Emma Barroso, Anna Gumà, et al.Hepatology (Baltimore, Md.)|December 5, 2008
Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase ARicardo Rodríguez-Calvo, Emma Barroso, Lucía Serrano, et al.Biochemical Pharmacology|July 11, 2026
Targeting the liver-brain axis: Licochalcone A as a therapeutic agent against HFD-induced neurodegenerationMarina Carrasco, Leila Driouech, Laura Guzman, et al.Pageof 7